-- Castle Rock Hormone Health (CRHH), a hormone optimization and replacement franchise, announced continued expansion of its franchise development strategy as multi-unit franchise operators increasingly evaluate cash-pay, membership-based healthcare concepts as part of their growth plans.
According to the company, operators are reviewing CRHH’s model for its recurring revenue structure, standardized clinical systems, and ability to scale across multiple territories. The company says its platform includes hormone therapy, medically guided weight loss, and anti-aging services for men and women, supported by a franchise roadmap targeting 100 to 250 new clinics in 2026 and an estimated 1,000 clinics nationwide over the next five years.
Healthcare has become an area of interest for experienced franchise operators seeking sectors with recurring service usage and sustained consumer demand. In that environment, CRHH says it is seeing increased attention from investors studying proactive health concepts that operate outside traditional insurance reimbursement models.
The company reports that it has served more than 10,000 patients nationwide to date and generated more than $10 million in annual revenue, with approximately 25% year-over-year growth ahead of its planned scale-up. According to CRHH, those figures are among the factors multi-unit owners are using to assess unit-level performance and broader network scalability.
Many operators are also evaluating cash-pay healthcare models for their billing simplicity, transparent pricing structure, and potential operating efficiencies. CRHH says its membership-based framework is designed around recurring care, ongoing patient relationships, and regular monitoring, which may support more predictable monthly revenue and longer-term customer retention.
“Multi-unit operators consistently seek models that combine strong unit economics with meaningful consumer relevance,” said Tyler Altenhofen, Chief Growth Officer and Co-Founder of Franchise Sidekick. “Membership-based healthcare provides a structure that many investors view as both operationally stable and aligned with long-term demand.”
Standardization remains a key factor for operators assessing whether a health concept can scale across multiple markets while maintaining consistency. According to the company, CRHH uses standardized clinical protocols developed by Dr. Lee Moorer, Castle Rock Hormone Health Co-Founder and CMO, along with centralized training systems and an operating framework for clinical and non-clinical teams.
CRHH says its clinics are designed to provide consultations, lab review, and ongoing monitoring within a concierge-style setting. The company positions that structure as part of a broader effort to offer a consistent patient experience while supporting franchisees with repeatable systems.
“Recurring care models support consistent patient engagement while providing operators with predictable revenue visibility,” said Christopher Stolzman, CEO of Castle Rock Hormone Health. “This structure creates alignment between ongoing service delivery and long-term business sustainability.”
The company added that Franchise Sidekick connects Castle Rock Hormone Health with qualified, vetted franchise candidates through its national advisor network. Every prospect has been evaluated for financial readiness and operator fit before entering the discovery process — ensuring the brand is growing with the right people.
About
Castle Rock Hormone Health is a hormone optimization and replacement franchise serving men and women across multiple U.S. regions, including the East Coast, Midwest, and Rocky Mountain markets. The company provides hormone therapy, medically guided weight loss, peptide and IV therapies, and related services aimed at addressing hormone imbalance and associated symptoms for a growing national patient base exceeding 10,000 individuals to date.
Contact Info:
Name: Carlos Conde
Email: Send Email
Organization: Castle Rock Hormone Health
Website: http://www.CRhormonehealth.com
Release ID: 89189658
Google
RSS